Boehringer Ingelheim Animal Health
- Biotech or pharma, animal health
Boehringer Ingelheim is a world-leading, research-driven biopharmaceutical company and a global leader in both animal and human health. We focus on delivering breakthrough innovation - wherever it originates - to tackle the most important scientific challenges we face. That's why we're one of the industry's leading investors in animal health innovation, with an investment of €500 million in 2024 for the research and development of future breakthroughs to improve the health and well-being of animals. It’s also why collaborations, with both animal health and human pharma partners, are an essential component of our innovation strategy. And with more than 250 collaborations worldwide and 8 out of 10 of our top-selling products anchored in external innovation, partnerships are helping us address unmet needs in many areas of animal health.
Address
DuluthGeorgia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}